DRAXIMAGE, Inc., headquartered in California, is a leading player in the medical imaging industry, specialising in the development and distribution of radiopharmaceuticals. Founded in 2004, the company has established a strong presence in North America and beyond, focusing on innovative solutions for diagnostic imaging and therapeutic applications. With a commitment to quality and safety, DRAXIMAGE offers a range of core products, including radiopharmaceuticals for nuclear medicine, which are distinguished by their high purity and efficacy. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Recognised for its dedication to advancing healthcare, DRAXIMAGE continues to contribute to the evolving landscape of medical imaging, ensuring better patient outcomes through cutting-edge technology.
We don't have data for DRAXIMAGE, Inc., but we can show you information about their parent organization instead.
View parent company